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Abstract
The prevalence of type 2 diabetes (T2D) is rapidly increasing, and effective strategies to manage and prevent this
disease are urgently needed. Resistance training (RT) promotes health benefits through increased skeletal muscle
mass and qualitative adaptations, such as enhanced glucose transport and mitochondrial oxidative capacity. In
particular, mitochondrial adaptations triggered by RT provide evidence for this type of exercise as a feasible lifestyle
recommendation to combat T2D, a disease typically characterized by altered muscle mitochondrial function.
Recently, the synergistic and antagonistic effects of combined training and Metformin use have come into question
and warrant more in-depth prospective investigations. In the future, clinical intervention studies should elucidate
the mechanisms driving RT-mitigated mitochondrial adaptations in muscle and their link to improvements in
glycemic control, cholesterol metabolism and other cardiovascular disease risk factors in individuals with T2D.
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Background
The significance of resistance training for individuals with
type 2 diabetes: moving beyond what we already know
The prevalence of type 2 diabetes (T2D) continues to in-
crease. Within the next 20 years, the number of people
affected by this disease is expected to reach almost 600
million worldwide [1]. T2D is accompanied by a host of
risk factors including dyslipidemia, hypertension and
cardiovascular disease [2], thus putting a severe burden
on our global health care systems. Apart from medica-
tion, chronic exercise (i.e. systematic training performed
repeatedly) is a proven prevention and treatment strat-
egy for individuals with pre-diabetes and T2D [3–5]. Re-
cent reviews and meta-analyses, including the 2016 joint
position statement on physical activity and T2D from
the American Diabetes Association [6], have highlighted
the beneficial effects of chronic endurance training (ET),
resistance training (RT) and/or combined (ET + RT) inter-
ventions for ameliorating insulin sensitivity and glycemic
control in individuals with T2D [7, 8]. Chronic ET alone
has a well-established role in enhancing insulin sensitivity
via glucose uptake and disposal (reviewed in [9]) and in
increasing muscle mitochondrial density and oxidative
capacity [10]. A limited number of studies have demon-
strated that chronic RT alone enhances glycemic control
[11, 12] and muscle substrate metabolism in individuals
with T2D [13], yet the underlying mechanisms inducing
these health benefits, particularly those related to muscle
mitochondrial function, remain to be elucidated.
The present review focuses on the effects of chronic
RT on glycemic control, substrate metabolism and the
molecular mechanisms that may influence these adapta-
tions in individuals with T2D. We place a special em-
phasis on skeletal muscle, the interaction between anti-
diabetic medication use and training stimulus, and in-
corporate adipose tissue as another significant target
organ for RT-mediated metabolic adaptations in T2D.
Since little is known about the independent effects of
chronic RT on mitochondrial adaptations in skeletal
muscle and adipose tissue of individuals with T2D, we
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important questions that future RT-focused trials in in-
dividuals with T2D will hopefully address. Improving
our understanding of the mechanisms underpinning
chronic RT-mitigated metabolic adaptions in T2D will
move the scientific community (researchers and clini-
cians alike) beyond what we already know and toward
future investigations focused on molecular determinants
of the individual training responses in T2D.
Chronic resistance training effects on muscle
mass, fiber type and glycemic control
Resistance training-induced gains in muscle mass are not
solely responsible for improved muscle substrate metab-
olism in type 2 diabetes
Skeletal muscle is responsible for ~80% of insulin-
mediated glucose uptake in the postprandial state [14],
and uptake is markedly blunted in individuals with T2D
[15]. In fact, when compared with lean healthy individ-
uals, skeletal muscle of individuals with T2D exhibits a
decreased capacity to oxidize both glucose and fat [16].
Chronic RT increases muscle mass and strength, largely
due to induction of muscle hypertrophy and neuromus-
cular remodeling [17] through the phosphatidylinositol 3
kinase (PI3K)- Akt - mammalian target of rapamycin
(mTOR) pathway [18] (Fig. 1). These gains are typically
associated with and often surmised to underlie improve-
ments in muscle substrate (glucose and fat) metabolism
even in the absence of direct evidence. Recent reports
have shown that in addition to increasing strength [12],
9 months of RT enhanced oxidation of both fatty acid-
and glycolytic-derived substrates in skeletal muscle of in-
dividuals with T2D [13]. The 1.4 kg increase in muscle
mass observed was interpreted to be the root cause of
these metabolic adaptations, yet many other factors such
as improvements in insulin signaling could be respon-
sible for the RT-induced improvements in substrate me-
tabolism and glycemic control [19]. At the molecular
level, calmodulin-dependent protein kinase (CaMK) II, a
critical sensor for intracellular calcium signaling and
muscle remodeling, is activated in an exercise intensity-
dependent manner. CaMK II phosphorylates transcrip-
tion factors such as histone deacetylases (HDACs) [20],
which upon phosphorylation are exported from the nu-
cleus leading to activation of transcription factors such
as myocyte enhancing factor (MEF) 2 and its target
genes [e.g., peroxisome proliferator-activated receptor-
gamma coactivator 1 alpha (PGC-1α), glucose trans-
porter protein 4 (GLUT4), thereby improving glycemic
control [21] (Fig. 1). Of note, a recent review assessing
the different characteristics of ET, RT and combined
training interventions and their associations with gly-
cemic control among individuals with T2D concluded
that increasing the number of exercise sessions (by vol-
ume and frequency) showed greater benefits than either
mode or intensity of the training itself [22]. Unfortu-
nately, data regarding the effects of varied intensities
and durations of RT on muscle mass are limited. To this
point, when expressed per kilogram of body weight, glu-
cose disposal rates are ~40–45% higher in weightlifter-
s—individuals characterized by large amounts of muscle
mass—compared to untrained individuals [23]; however,
when normalized to muscle mass, glucose disposal rates
no longer differ between weightlifters and untrained
controls. These results underline the importance of un-
derstanding that chronic RT can have separate but
equally important impacts on skeletal muscle in terms of
strength and substrate utilization, and that while in-
creased muscle mass can contribute to enhanced whole-
body glucose-disposal rates, it does not necessarily sug-
gest that the exercise regimen altered the inherent cap-
acity of muscle to more effectively metabolize substrate.
Metabolic adaptations within skeletal muscle in response
to resistance training: how much does fiber type matter?
Type IIx fibers are described as having a glycolytic pheno-
type, relying on glucose more than fat as a fuel, and facili-
tating short-duration anaerobic activities. It has been
shown that Type IIx fibers are present in a higher propor-
tion in individuals with T2D [4]. Hyperinsulinemia—a
hallmark feature of insulin resistance and T2D—can shift
muscle fiber type toward a glycolytic phenotype by in-
creasing Type IIx myosin heavy chain gene expression [5].
Physical inactivity and immobilization have similar effects
on fiber type shift [21]. Interestingly, first-degree relatives
of individuals with T2D have a ~30% higher proportion of
Type IIx fibers than individuals without a family history of
T2D. Type IIx fiber content was also negatively associated
with glucose disposal rates in these same individuals [6].
Paradoxically, elite strength and speed athletes have a high
proportion of Type IIx fibers and are metabolically
healthy, yet the high proportion of Type IIx fibers ob-
served in individuals with T2D is concomitant with overall
blunted substrate oxidation and appears to be less advan-
tageous for these individuals. It is tempting to speculate
that the high number of Type IIx fibers in individuals with
T2D could be “trained” to utilize fuel more effectively as
observed in strength-based athletes. Four to six weeks of
moderate intensity RT (at 40–50% of the one-repetition
maximum, 1RM) markedly increased skeletal muscle glu-
cose uptake in non-obese individuals with T2D [24],
which was largely attributed to a shift in fiber type toward
Type IIa fibers. Single fiber analysis revealed that Type IIa
fibers were the ones with the highest glucose uptake and
GLUT4 content among the Type II fiber population [25,
26]. Type IIa fibers also had a higher capillary density and
showed a greater insulin response than Type IIx fibers
[27]. Although Type IIa fibers exhibited more marked
glycogen depletion during an exercise bout and faster
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glycogen re-synthesis following the exercise bout [28], it
remains to be determined whether altering fiber type dis-
tribution benefits individuals with T2D in this respect. It is
entirely possible that fiber type composition is irrelevant if
the cellular metabolic machinery (e.g., glucose transport,
mitochondria, etc.) is dysfunctional. In other words, quan-
tity does not necessarily equal quality. Challenging the
idea that switching fiber type confers a metabolic advan-
tage, two independent studies demonstrated that chronic
RT-driven improvements in insulin responsiveness and
high-density lipoprotein (HDL) levels in individuals with
T2D occurred without any changes in fiber type compos-
ition [29, 30], a phenomenon routinely observed in
healthy individuals [31]. Metabolic adaptations within
muscle can therefore occur independently of a change in
muscle fiber type composition. It is important to note that
direct comparisons of the effects of different durations
and intensities of RT on fiber type composition are virtu-
ally absent from the literature.
Chronic resistance training and mitochondrial
fitness
Resistance training effects on muscle mitochondrial
function in individuals with type 2 diabetes: how much
do we really know?
Perturbations in mitochondrial oxidative capacity play a
major role in the development and progression of insu-
lin resistance and T2D [32]. As few as 3 days of high-fat
feeding are sufficient to induce insulin resistance and re-
duce muscle mitochondrial oxidative phosphorylation at
Fig. 1 Summarizes the physiological stimuli, triggered by resistance training and the specific molecular signaling events leading to a number of
beneficial adaptive responses. These multifactorial benefits induced by resistance training can either be mediated independently of an increase in
muscle mass (e.g., increased key insulin signaling proteins resulting in improved insulin action, enhanced post-exercise oxygen consumption
resulting in a decrease of adipose tissue mass, increased mitochondrial content positively affecting fatty acid oxidation capacity and improved
glucose homeostasis due to augmented rates of glycogen synthesis). The benefits can also be associated with an increase in muscle mass (e.g.,
improved glycemic control via increased glucose transporter 4 protein expression, increased resting energy expenditure and metabolic demand
via increased muscle protein turnover). Increased substrate oxidation during exercise can alter redox state and energy charge, signaling for activa-
tion of SIRT family members and AMPK. Downstream activation of PGC-1α and FOXO1 can promote fatty acid oxidation, mitochondrial biogenesis
and increased antioxidant effects. ROS signaling during exercise can also promote mitochondrial function and bolster antioxidant defense via
SOD, GPX and PRDX. Mechanical stress (e.g., contraction) during exercise triggers calcium signaling that promotes glucose uptake via GLUT4,
muscle growth and differentiation via MEF2 and Akt-mTOR, and has a negative effect on the activity of FOXO family members (FOXO1, FOXO3a),
minimizing autophagy and muscle atrophy. Please see text for more information. Adapted from [92]. Abbreviations: AMP: Adenosine monophosphate;
AMPK: Adenosine monophosphate activated kinase; ATF: activating transcription factor; CaMK: Ca2+/calmodulin-dependent protein kinase; CREB: cAMP
response element-binding protein; ERK: extracellular signal–regulated kinase; FOXO: Forkhead box protein O; GLUT4: glucose transporter 4; HDAC: Histone
deacetylases; IL-6: interleukin 6; JNK: c-Jun N-terminal kinases; mTOR: mammalian target of rapamycin; MEF: myocyte enhancing factor; NAD/H+: Nicotinea-
mide adenine dinucleotide; NRF1/2: nuclear respiratory factor 1/2; p70 S6K: ribosomal protein S6 kinase beta-1; PGC1-α: peroxisome proliferator-activated
receptor gamma co-activator 1-alpha; PI3K: phosphatidylinositol-3-kinases; ROS: reactive oxygen species; SIRT: silent mating type information regulation
homolog; TFAM: mitochondrial transcription factor A;
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the transcriptional level in lean, sedentary individuals
[33]. Individuals with T2D have reduced mitochondrial
oxidative capacity when expressed per unit of muscle
mass compared to healthy individuals; however, when
mitochondrial oxidative capacity is normalized to
markers of mitochondrial content (e.g., mitochondrial
DNA copy number, citrate synthase activity), these dif-
ferences are insignificant [16, 34]. That being said, dis-
rupted mitochondrial morphology and a 35% reduction
in mitochondrial size reported in individuals with T2D
are indicative of functional impairment [16].
Aerobic and combined training improve mitochondrial
function [35]. Mechanical stress induces activation of
the mitogen-activated protein kinase (MAPK) family of
proteins (extracellular-regulated kinase (ERK1/2) and
p38 MAPK). Activation of p38 MAPK during contrac-
tion stimulates activating transcription factor (ATF) 2
and MEF2, which increase PGC-1α expression and im-
prove mitochondrial function in skeletal muscle (Fig. 1)
[36]. Some evidence to support a role for chronic RT in
increasing muscle mitochondrial oxidative capacity ex-
ists in healthy individuals [37–39]; however, similar data
in individuals with T2D are limited. RT (alone or in
combination with ET) has only recently been recognized
as a promising intervention to maintain muscle mito-
chondrial oxidative capacity [40] and improve the overall
metabolic phenotype of individuals with T2D [13, 41].
Discrepancies in the measured outcomes and the details
of the training protocols implemented in RT
interventions have made it difficult to ascertain the value
of implementing chronic RT to improve muscle mito-
chondrial function in individuals with T2D.
Twelve weeks of RT (50–75% of 1RM) twice per week
failed to alter PGC-1α protein content and mitochon-
drial transcription factor A (TFAM) RNA content in in-
dividuals with T2D, indicating that this particular
duration and/or intensity was not sufficient to induce
changes in key regulatory molecules of mitochondrial
biogenesis [42]. As mentioned previously, however,
quantity does not necessarily equal quality, and the topic
of mitochondrial number vs. function is highly debated.
According to the classical view of training adaptations,
RT signals through the Akt-mTOR-S6K pathway by
which it promotes muscle hypertrophy though myofi-
brillar protein biosynthesis. ET leads to an activation of
adenosine monophosphate activated kinase (AMPK) and
subsequent activation of PGC-1α, inducing mitochon-
drial biogenesis [43] (Fig. 2). On the contrary, a recent
study demonstrated two-fold higher mRNA expression
levels of PGC-1α, PGC-1-related coactivator (PRC) and
pyruvate dehydrogenase kinase 4 (PDK4) in a group that
performed RT after ET vs. a group that performed ET
alone [44]. This suggests that combined (RT + ET) train-
ing amplifies the molecular response to ET alone. De-
creased energy charge, or an elevated [AMP]/[ATP] ratio
in response to contraction, and subsequent AMPK activa-
tion possibly mediates changes towards an improved oxi-
dative phenotype by phosphorylating and activating the
Fig. 2 Biguanides such as metformin exert their action via inhibition of complex I, mitochondrial glycerophosphate dehydrogenase and ATP
synthase, thereby increasing [AMP]/[ATP] ratio, activating AMPK and increasing insulin sensitivity. ET acts in part through the same pathway,
suggesting that these two stimuli could act synergistically. The effect of a RT regimen on individuals with T2D currently taking metformin and
other anti-diabetic drugs remains to be determined
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transcription factor cAMP-response-element binding pro-
tein (CREB), which increases PGC-1α transcriptional ac-
tivity. Exercise-mediated perturbation of redox potential
or the [NAD+]/[NADH] ratio will also promote the deace-
tylation activity of silent mating-type information regula-
tion (SIRT) 1 and 3, which further potentiate PGC-1α
transcriptional activity [45, 46] (Fig. 1). SIRT1 and SIRT3
activity can lead to deacetylation of FOXO1, allowing nu-
clear translocation and increased expression of PDK4 that
triggers a switch from glucose to lipid oxidation. However,
FOXO activity (FOXO1 and FOXO3a) in the muscle has
also been implicated in increased autophagy and muscle
atrophy via increases in atrogin-1 expression. Interest-
ingly, exercise induction of FOXO activity via effects on
redox potential may face inhibitory crosstalk from
exercise-mediated activation of the Akt-mTOR pathways,
as Akt is known to phosphorylate FOXOs and exclude
them from the nucleus [47]. The roles of these seemingly
competing pathways in promoting mitochondrial function
via enhanced lipid metabolism but maintaining muscle
mass remain to be examined in the context of exercise
interventions.
One interesting theory on how to improve muscle
mitochondrial oxidative capacity in diabetes is via
‘gene shifting’. A recent report suggests that satellite
cell activation following chronic RT leads to incorpor-
ation of new mitochondrial DNA into mature muscle
cells [48]. This phenomenon, known as ‘gene shifting’,
may help normalize mitochondrial oxidative capacity
in individuals suffering from impaired mitochondrial
function by providing undamaged mitochondrial DNA
from which new, functional mitochondrial proteins
can be synthesized. In support of this hypothesis, a
supervised 14-week RT regimen (three times per week
at 50–80% of the 1RM) increased cytochrome c oxi-
dase (COX) activity, enhanced mitochondrial creatine
kinase levels and decreased oxidative DNA damage in
elderly men and women [49]. These findings suggest
that chronic RT up-regulates selected components of
the mitochondrial electron transport system which
may convey many of the beneficial effects of this ex-
ercise modality [50].
Collectively, these findings suggest that chronic RT is
capable of inducing muscle mitochondrial biogenesis
and enhancing downstream oxidative capacity. In
addition to biogenesis, mitochondria also undergo re-
modeling (i.e., fusion and fission) to enhance and/or pre-
serve function. RT can act as a trigger to induce
mitochondrial fission, followed by recovery-induced fu-
sion and mitochondrial biogenesis. These RT-triggered
processes may act as natural selection at the level of the
mitochondrion (mito-checkpoint) and eliminate disad-
vantageous mitochondria, thereby driving adaptive selec-
tion of advantageous phenotypic variations [51]. This
concept adds another dimension to the current under-
standing of chronic RT-mitigated improvements in
muscle mitochondrial health.
Resistance training-induced oxidative stress in type 2 dia-
betes: is defense the best offense?
T2D is characterized by excessive reactive oxygen spe-
cies (ROS) emission which presumably leads to oxidative
stress in different tissues [52, 53]. There are at least 11
sites in muscle mitochondria capable of producing ROS
and their rates under different (patho)physiological con-
ditions still need to be determined [54]. Recent estima-
tions assessing ex vivo mitochondrial superoxide/
H2O2 production in conditions mimicking physiological
states have reported that 0.35% of oxygen consumed at
rest is diverted to ROS production, and that this propor-
tion is reduced to 0.03–0.01% during exercise [55].
Given that mitochondria superoxide/H2O2 production is
likely to decrease during moderate exercise, it is import-
ant to also consider other cellular reactions and sites as
significant mediators of ROS production. Both ET and
RT increase oxidant production, which can lead to oxi-
dative stress [56, 57]. ROS can activate c-jun N-terminal
kinase (JNK) signaling as evidenced by a recent report
demonstrating that infusion of the antioxidant N-
acetylcysteine reduced JNK signaling during aerobic ex-
ercise training [58] (Fig. 1). Interleukin-6 (IL-6) is associ-
ated with a variety of metabolic effects across different
organs and its secretion during contraction is JNK-
dependent [59], emphasizing the importance of JNK sig-
naling and ROS-mediated JNK activation in facilitating
metabolic adaptations to aerobic exercise training [58].
In a comparative study assessing the effects of exhaust-
ive ET vs. RT on ROS production, both training modal-
ities increased oxidative stress; however, lipids were
affected by peroxidation only during RT, and proteins
were oxidized and formed carbonyls during ET [57].
Training frequency also impacts ROS production and
oxidative stress. While a single RT session was sufficient
to induce oxidative damage in untrained men [60], 6
months of RT (three times per week at 50–80% of the
1RM) induced whole-body adaptations resulting in de-
creased training-induced oxidative stress and homocyst-
eine levels [61]. Data on RT-mediated oxidative stress are
sparse in individuals with T2D. A recent study reported
that 12 months of supervised ET, RT and flexibility train-
ing equally reduced oxidative stress in men with T2D [62].
In addition to promoting acute ROS formation [63],
aerobic exercise training generally improves muscle anti-
oxidant defense mechanisms [64]. Interestingly, mito-
chondrial hydrogen peroxide (H2O2) production is
important for muscle differentiation in vitro, and
mitochondria-targeted antioxidant treatment with
MitoQ and MitoTEMPOL, as well as mitochondria-
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targeted catalase, blocks this effect [65]. As such, acute
ROS formation during RT may also have beneficial ef-
fects on muscle differentiation in vivo. Indeed, mito-
chondrial ROS generation might be involved in initiating
mitochondrial biogenesis [66]. Transient ROS “build-up”
has been suggested to prime the cellular redox system,
which culminates in an improved handling of subse-
quent pro-oxidant environments. Oxidative stress must
therefore be considered in connection with radical scav-
enging activities and cellular antioxidant defense mecha-
nisms. A 12-week RT intervention (twice per week at
50–75% of the 1RM) not only reduced oxidative stress,
but also significantly increased cytosolic and mitochon-
drial antioxidant proteins [superoxide dismutase-2
(SOD2), glutathione peroxidase-1 (GPX1), peroxiredoxin
isoform 5 (PRDX5), heat-shock-protein-70 (HSP70)] in
muscle of individuals with T2D [67].
Chronic RT effects on ROS production in human
muscle are relatively unexplored. Due to the absence of
reliable techniques to precisely measure ROS production
in vivo, fundamental questions regarding the sources of
ROS and the effects of training modalities on ROS sig-
naling remain unanswered. As such, more studies are re-
quired to elucidate how ROS affects the hypertrophic
and adaptive responses of human muscle to chronic RT,
especially in T2D. Unraveling these pathways could lead
to a better understanding of the potential therapeutic
role of antioxidant supplements in treating metabolic
impairments. Furthermore, it is important to consider
the interaction of medication or supplement use with
the antioxidant defense system (Fig. 2). A recent review
explored the novel hypothesis that attenuation of oxida-
tive stress from exercise training by these exogenous
compounds blunts beneficial metabolic adaptations [68].
Chronic resistance training and medication use
Metformin and exercise training in diabetes: the good,
the bad and the unknown
In recent years, the combined effects of metformin treat-
ment and training regimens on metabolic outcomes have
gained attention, the majority of these studies conducted
in healthy and/or pre-diabetic populations [69–73]
(Fig. 2). Metformin is the most widely prescribed first-
line oral anti-diabetic drug recommended by the Ameri-
can Diabetes Association (ADA). The exact molecular
mechanism of action underlying this drug’s physiological
benefits remains mysterious, although it is often pre-
scribed together with a regular exercise training program
as part of a lifestyle intervention. Metformin is known to
have pleiotropic effects and multiple potential target
pathways. One possible site of metformin action is inhib-
ition of mitochondrial respiratory system complex I, in-
creasing the [AMP]/[ATP] ratio (much like muscle
contraction does) and activating AMPK. AMPK
phosphorylation of multiple downstream effectors can
divert cellular metabolism towards restoration of energy
homeostasis [74], thereby improving insulin sensitivity
(Fig. 2). ET-mediated increases in insulin sensitivity also
act in part through AMPK activation [75], suggesting
that exercise training and metformin could have additive
effects. In support, a recent randomized, controlled
chronic exercise training (ET, RT, ET + RT) intervention
(22 weeks) in individuals with T2D demonstrated that
compared with controls, ET led to a significant reduc-
tion in HbA1c in metformin users (-0.57%) but not in
untreated individuals (-0.17%). However, metformin did
not have any effect on improvements in indicators of
aerobic fitness, strength, body weight or waist circumfer-
ence [76]. Importantly, this effect was only observed
with ET and ET + RT. The RT only group did not
achieve significant reductions in HbA1c (with or without
metformin) compared with the control group.
Alternatively, metformin was also documented to have
opposing effects on fat oxidation during and following a
single bout of ET in healthy individuals [77], and a re-
cent report demonstrated that metformin blunted the
full effect of 12 weeks of combined ET + RT on insulin
sensitivity by 25–30% in glucose intolerant individuals
[72]. This same investigation demonstrated that metfor-
min use blunted some of the beneficial effects of the
combined training related to a reduction in cardiovascu-
lar disease risk such as systolic blood pressure or high
sensitivity C-reactive protein (hs-CRP) [70]. These find-
ings conflict with an earlier investigation in insulin-
resistant individuals in which two to three weeks of met-
formin treatment blunted the effects of a single bout of
ET on insulin sensitivity [71]. The above studies suggest
some positive and negative interactions between metfor-
min use and adaptations to both single and repeated
bouts of ET and combined ET + RT on glycemic control.
Taken together, these data suggest that when exercise
training is implemented in a population of current met-
formin users, which is commonplace in a clinical setting,
it is important to consider how use of this medication
may affect an individual’s training response in terms of
glycemic control.
Biguanides such as metformin have also been recently
identified as a new class of mitochondrial glycerophos-
phate dehydrogenase (mGPD) [78] and ATP synthase in-
hibitors [79]. Inhibition of ATP synthase may affect
energetics in skeletal muscle and recovery of energy
charge during exercise. Inhibition of mGPD by metfor-
min leading to decreased cytosolic [NAD+]/[NADH]
may alter activity of SIRT1, decreasing deacetylation of
PGC-1α and reversing potential positive impact of exer-
cise on mitochondrial biogenesis. Also relevant is the re-
cent finding that metformin’s effect as a cancer
therapeutic is partially mediated by inhibition of mTOR,
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raising the question of whether metformin may influence
the positive effects of Akt-mTOR pathway activation on
muscle mass [20]. It remains to be determined how a
chronic RT regimen would impact individuals with T2D
currently taking metformin and other anti-diabetic drugs
(Fig. 2). More research on the detailed effects of metfor-
min on adaptations to ET and RT, especially in the context
of varying intensities and duration, is warranted. Further-
more, the significance of metformin effects directly in the
muscle at prescribed doses requires attention, as it is
thought that metformin primarily targets liver metabol-
ism. It is possible that metformin-mediated amelioration
of whole-body glucose homeostasis via inhibition of un-
controlled liver gluconeogenesis may be enough to restore
muscle insulin sensitivity and therefore promote beneficial
effects of exercise training in the muscle. Based on current
evidence, we speculate that in the muscle, anti-diabetic
drugs such as metformin – due to inhibition of complex I
of the electron transport system and subsequent AMPK
activation – may interfere with adaptations to ET to a
greater extent than RT, which recruits a different signaling
cascade than AMPK. This could possibly establish RT as a
reasonable training modality for a cohort taking metfor-
min, particularly those individuals with T2D.
Chronic resistance training and adipose tissue
Adipose tissue is an important (and understudied) target
organ of resistance training in diabetes
Studies of exercise training, chronic RT in particular, on
white adipose tissue (WAT) remodeling in humans are
sparse. WAT secretes two major pro-inflammatory cyto-
kines: interleukin-6 (IL-6) and tumor necrosis factor-
alpha (TNF-α). Obesity is characterized by a state of
chronic low-grade inflammation, which is implicated in
the pathogenesis of T2D [80], and circulating levels of
both IL-6 and TNF-α are inversely related to glycemic
control and insulin sensitivity [81]. Modulation of low-
grade inflammation by 12 weeks of ET (40 minutes at
60–80% of the maximal heart rate) and RT (three times
per week at 60–80% of the 1RM) was investigated in
obese individuals with T2D. Although ET was more ef-
fective in reducing adipocytokines in response to the
chronic training, RT also significantly reduced circulat-
ing levels of TNF-α and IL-6 [82]. RT for 16 weeks
(three times per week at 60–85% of the 1RM) in obese
adolescents significantly reduced IL-6 and TNF-α
plasma levels, and changes in muscle strength were dir-
ectly related to changes in pro-inflammatory cytokines
[83]. These data suggest that chronic RT induces a sig-
naling pathway that alleviates systemic inflammation. In
another study, 12 weeks of supervised RT (3 days per
week) in individuals with T2D decreased plasma levels
of hs-CRP, a non-specific marker of inflammation, and
increased the beneficial adipokine Visfatin [84].
According to some studies [85, 86] excess post-exercise
oxygen consumption is higher after RT than after ET.
This phase is characterized by utilization of fat as a fuel,
which could benefit weight loss [87]. Although data are
limited, collectively, these studies highlight the systemic
anti-inflammatory effects of RT (presumably via WAT)
and the potential of chronic RT to improve body com-
position and alleviate chronic low-grade inflammation
associated with obesity and T2D. How chronic RT af-
fects WAT function (e.g., fibrosis, angiogenesis, brown-
ing, etc.) and signaling pathways within the organ itself
are areas of research that require greater attention and
could shed light on exercise training targets that elicit a
positive metabolic response in individuals with T2D.
Closing remarks
Future directions – toward personalized medicine?
Due to the large inherent variability of responses to the
same RT program, general recommendations are less
than ideal. The future of T2D research is moving in the
direction of personalized medicine. Current research in
this area continues to discover signaling pathways that
differ even amongst the most homogenous groups of in-
dividuals, and these differences ultimately lead to varia-
tions in their physiological responses to medications and
treatments. It is imperative that we exploit these inter-
individual responses following exercise training interven-
tions in individuals with T2D to maximize each person’s
beneficial adaptation to a training program. A clear dis-
tinction of the different types of RT will be necessary for
the implementation of exercise training as a feasible life-
style modification in light of current and future progres-
sion toward personalized medicine. Different RT
programs (with varying intensities) will lead to diverse
results and metabolic outcomes, and this cause-effect re-
lationship must be clearly established for RT in order to
maximize the benefits for individuals with T2D. In this
effort, more research comparing supervised ET interven-
tions with RT interventions of varying intensities, dura-
tions and volumes including long-term training studies
using different modes of periodization, is required. This
will further elucidate exercise-mediated effects on
whole-body metabolism and muscle mitochondrial func-
tion, specifically in individuals with T2D. In addition, the
effects of RT on other major target organs, such as
WAT, require deeper investigation.
Another question to be addressed is whether the
underlying mechanisms by which chronic RT improves
muscle glucose regulation are the same as those utilized
by chronic ET. It is necessary to determine which path-
ways are recruited by each type of exercise training, once
again due to the possibility that one training method
may impart greater benefit to certain individuals than to
others as a result of their genetic makeup, physiology,
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and current medication use. Differences in sex, age and
ethnicity likely contribute to the distinct outcomes of
several studies looking at the metabolic effects of endur-
ance and resistance training, even when the exercise
protocol itself remains the same. While some studies re-
port beneficial effects of RT on diverse metabolic param-
eters [19, 88, 89], others do not [90, 91]. It is therefore
critical to report the training load, duration and relative
intensity when comparing different groups of individ-
uals. Addressing why discrepancies exist in outcomes
from studies where individuals trained at similar inten-
sities and duration may hold the key to effectively in-
corporate exercise training in the treatment of metabolic
disease on a personalized level.
Conclusions
RT is a promising strategy to promote overall metabolic
health in individuals with T2D via improvements in
muscle mitochondrial performance and increases in
muscle mass that may positively impact insulin respon-
siveness and glucose control. Multifactorial events con-
tribute to the beneficial adaptations elicited by chronic
RT (Fig. 1). A consistent regimen of RT at moderate in-
tensity elicits the most beneficial metabolic response-
s—in terms of HbA1c and insulin sensitivity—in
individuals with T2D. Current exercise recommenda-
tions should ideally be a synthesis of gains in muscle
mass (higher intensity RT) and mitochondrial oxidative
capacity (lower intensity RT or ET), as well as aim to re-
duce circulating pro-inflammatory cytokines (targeting
WAT), in order to fully exploit the salutary effects of
training on overall metabolic health. This can most effi-
ciently be achieved by utilizing combined (RT and ET)
training regimes. Another important consideration for
current diabetes treatment guidelines is the use of met-
formin in combination with exercise training as the
question of synergism vs. antagonism remains un-
answered (Fig. 2). Combinations of lifestyle interventions
(e.g., such as medication use, caloric restriction and
weight loss) may offer additional benefits and additive
effects to a RT regime.
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